Business & Finance

Global Active Pharmaceutical Ingredients (API) Market Analysis & Forecast 2019

In this report, the Global Active Pharmaceutical Ingredients (API) Market Analysis & Forecast 2019 market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Global Active Pharmaceutical Ingredients (API) Market Analysis & Forecast 2019 market has been broken down by major regions, with complete market estimates on the basis of products/applications on a regional basis.

Browse full research report at https://www.crystalmarketreport.com/global-active-pharmaceutical-ingredients-api-market-analysis-andamp;-forecast-2019

Crystal Market Reports

An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.

The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Active Pharmaceutical Ingredients includes synthetic APIs, biotech APIs, and the proportion of synthetic APIs in 2017 is about 85%, and the proportion is in decreasing trend from 2012 to 2017.

Active Pharmaceutical Ingredients is widely used in CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology and other field. The most proportion of Active Pharmaceutical Ingredients is used for cardiovascular, and the proportion in 2017 is 21%.

The global Active Pharmaceutical Ingredients (API) market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Active Pharmaceutical Ingredients (API) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Active Pharmaceutical Ingredients (API) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

Teva

Mylan

DSM

Aurobindo Pharma

Aspen

Novartis

BASF

Pfizer

Huahai Pharmaceutical

Hisun Pharmaceutical

Sun Pharmaceutical Industries

Zhejiang Medicine

Dr. Reddy’s Laboratories

Zhejiang NHU

Bayer

NCPC

AbbVie

Shandong Xinhua Pharmaceutical

Northeast Pharm

Harbin Pharmaceutical

LKPC

Segment by Regions

North America

Europe

China

Japan

Segment by Type

Synthetic APIs

Biotech APIs

Segment by Application

CNS

Cardiovascular

Genitourinary/Hormonal Drugs

Respiratory

Rheumatology

Diabetes

Oncology

Others

Browse full research report at https://www.crystalmarketreport.com/global-active-pharmaceutical-ingredients-api-market-analysis-andamp;-forecast-2019

Reasons to Buy This Research Report

About Crystal Market Reports

Crystal Market Reports is a distributor of market research spanning 160 industries. Our extensive database consists of over 400,000 quality publications sourced from 400 plus publishers, this puts our research specialists in the unique position of been able to offer truly unbiased advice on what research provides the most valuable insights.

Contact Info.:-

Address: 90 State Street
Suite 700 Albany
New York 12207
Email: [email protected]
Web: https://www.crystalmarketreport.com

Close